Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 17, 2004New England Journal of Medicine

Prior-Authorization Programs for Controlling Drug Spending

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMary Beth HamelBeth Israel Deaconess Medical CenterAEArnold M. EpsteinBrigham and Women's Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hamel et al. (2004) studied this question.

synapsesocial.com/papers/6a759dffbff0e42c1b160d16https://doi.org/10.1056/nejmp048294
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Trends In U.S. Health Care Spending, 20012003 · 180 citations
  2. 2The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and Spending2003 · 336 citations
  3. 3The Pharmaceutical Industry versus Medicaid — Limits on State Initiatives to Control Prescription-Drug Costs2004 · 22 citations
  4. 4Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors2004 · 114 citations